  id.exposure   id.outcome                                            outcome
1   met-a-427 finn-b-G6_MS MS-disease / Multiple Sclerosis || id:finn-b-G6_MS
2   met-a-427 finn-b-G6_MS MS-disease / Multiple Sclerosis || id:finn-b-G6_MS
3   met-a-427 finn-b-G6_MS MS-disease / Multiple Sclerosis || id:finn-b-G6_MS
4   met-a-427 finn-b-G6_MS MS-disease / Multiple Sclerosis || id:finn-b-G6_MS
5   met-a-427 finn-b-G6_MS MS-disease / Multiple Sclerosis || id:finn-b-G6_MS
                              exposure                    method nsnp         b       se
1 2-hydroxyisobutyrate || id:met-a-427                  MR Egger    3 -3.438496 6.491155
2 2-hydroxyisobutyrate || id:met-a-427           Weighted median    3 -2.320968 1.458096
3 2-hydroxyisobutyrate || id:met-a-427 Inverse variance weighted    3 -1.709091 1.952448
4 2-hydroxyisobutyrate || id:met-a-427               Simple mode    3 -3.374075 2.067337
5 2-hydroxyisobutyrate || id:met-a-427             Weighted mode    3 -2.576120 1.652039
       pval
1 0.6898770
2 0.1114343
3 0.3813790
4 0.2442509
5 0.2592603
